Production (Stage)
Raia Drogasil S.A.
RADLY
$2.47
-$0.17-6.44%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.50% | -4.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.50% | -4.21% | |||
| Cost of Revenue | 0.81% | -4.04% | |||
| Gross Profit | -3.62% | -4.61% | |||
| SG&A Expenses | -2.32% | 0.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -205.83% | 32.33% | |||
| Total Operating Expenses | -0.77% | -2.89% | |||
| Operating Income | 4.69% | -24.34% | |||
| Income Before Tax | -28.24% | -40.00% | |||
| Income Tax Expenses | 150.95% | -164.54% | |||
| Earnings from Continuing Operations | -52.64% | -2.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1,017.87% | 102.80% | |||
| Net Income | -52.98% | -1.40% | |||
| EBIT | 4.69% | -24.34% | |||
| EBITDA | 4.02% | -19.29% | |||
| EPS Basic | -52.91% | -1.37% | |||
| Normalized Basic EPS | -18.13% | -27.78% | |||
| EPS Diluted | -53.19% | -0.82% | |||
| Normalized Diluted EPS | -18.13% | -27.20% | |||
| Average Basic Shares Outstanding | -0.19% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.30% | -0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | 203.29% | |||